InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Lindmark Bertil, Directeur médical. Director active across 1 companies, notably Galecto, Inc.. Aggregated, 3 filings have been logged. Total volume traded: €46k. The latest transaction was disclosed on 22 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations3 total
14,604 shares@ €1.960661.9% of flowCommon StockSEC:0001209191-22-020683:0
Ideal exit: 17 Dec 2022 (T+270)
2,000 shares@ €4.4095100.0% of flowCommon StockSEC:0001209191-21-043464
Ideal exit: 25 Mar 2022 (T+270)
2,000 shares@ €4.409519.1% of flowCommon StockSEC:0001209191-21-043464:0
Ideal exit: 25 Mar 2022 (T+270)
3 of 3 declarations
About Lindmark Bertil
Bertil Lindmark is the Chief Medical Officer at Galecto, Inc. He is responsible for medical strategy and oversight of clinical operations. His role is essential in ensuring that Galecto adheres to medical and ethical standards.
